한글목차

구급차 시장 규모는 2023년 35억 1,252만 달러에서 예측 기간 동안 7.28%의 연평균 복합 성장률(CAGR)을 나타내고, 2032년에는 66억 938만 달러 규모에 달할 전망입니다.

지역별 인사이트

예측 기간 동안 아시아태평양은 계속해서 지배적인 위치를 차지할 것으로 예상됩니다. 당뇨병, 심장병, 암과 같은 만성질환의 유병률 증가가 이 지역의 구급차 서비스 시장의 성장을 주도하고 있습니다. 국제당뇨병연맹(International Diabetes Federation, IDF)의 예측에 따르면, 2030년과 2045년까지 동남아시아 국가들의 당뇨병 환자 수는 크게 증가할 것으로 예상됩니다. 환자 수가 크게 증가할 것으로 전망하고 있습니다. 이 지역의 주요 사망원인인 심혈관 질환(CVD)은 효율적인 구급차 서비스를 필요로 합니다. American College of Cardiology Foundation의 데이터는 아시아에서 CVD가 사망률에 미치는 심각한 영향을 강조하며, 심장 관련 급성 증상이 발생한 환자에게 적시에 고급 의료 서비스를 제공하는 구급차 서비스의 중요한 역할을 강조하고 있습니다. 강조했습니다.

또한, 아시아태평양 전체의 의료비 증가는 구급차 시장의 성장을 가속하고 있습니다. 중국과 같은 국가에서는 의료 인프라에 대한 대규모 투자가 이루어지고 있어 의료 서비스의 질과 접근성이 향상되고 있습니다. 의료비 증가는 응급 대응 능력을 향상시킬 뿐만 아니라 의료 시스템 확대로 이어져 고도로 훈련된 직원과 최첨단 장비를 갖춘 구급차 서비스의 필요성이 증가하고 있습니다.

세계의 구급차(Ambulance) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 요인과 시장 기회 분석, 시장 규모 추이와 예측, 각종 부문별/지역별/주요 국가별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 조사 방법

제4장 시장 역학

• 성장 촉진요인
• 성장 억제요인
• 기회
• 과제
• COVID-19의 영향 분석
• 시장 동향

제5장 시장 요인 분석

• 밸류체인 분석
• Porter의 Five Forces 분석
• SWOT 분석
• PESTEL 분석
• 특허 동향 분석
• 규제 전망
• 현재 시장과 전망
• 향후 혁신
• 동향 분석

제6장 세계의 구급차 시장 : 기준별

제7장 세계의 구급차 시장 : 유형별

제8장 세계의 구급차 시장 : 사이즈별

제9장 세계의 구급차 시장 : 추진 구분별

제10장 세계의 구급차 시장 : 용도별

제11장 세계의 구급차 시장 : 변속기 유형별

제12장 세계의 구급차 시장 : 지역별

• 세계
• 북미
• 유럽
• 아시아태평양
• 중동 및 아프리카
• 남미 및 중앙아메리카

제13장 경쟁 구도

• 경쟁 대시보드
• 시장 점유율 분석
• 주요 전개 및 성장 전략

제14장 기업 개요

• BOLLANTI
• EMS MOBIL SISTEMLER A.S.
• RMA GROUP
• NAFFCO GROUP
• BRAUN INDUSTRIES, INC
• AMBULANCEMED
• AMERICAN SPECIALITY VEHICLES
• BERGADANA
• C. MIESEN GMBH & CO. KG
• DELTAMED

제15장 부록

영문목차

Global Ambulance Market 2032

Market Overview

Ambulance market industry is projected to develop from USD 3,512.52 Million out of 2023 to USD 6,609.38 Million by 2032, displaying a build yearly development rate (CAGR) of 7.28% during the forecast time frame.

Different setups and types of ambulances are accessible to oblige different clinical requests and transportation determinations. As a delineation, ambulances assigned as essential life support (BLS) are equipped to take care of non-basic clinical circumstances and convey principal clinical consideration. On the other hand, high level life support (ALS) ambulances are outfitted with best-in-class clinical contraption and set up with paramedics who can oversee drugs and execute progressed operations. Moreover, aside from regular ground ambulances, air ambulances, likewise alluded to as clinical helicopters or fixed-wing airplane, effectively convey patients to far off regions or over broad distances where clinical offices are scant.

Also, where admittance to specialty care might be restricted in remote or underserved regions, the combination of telemedicine advancements into ambulances empowers the arrangement of clinical benefits, including injury the board, cardiovascular mediations, and stroke care. As a delineation, tele stroke programs work with correspondence between stroke patients and nervous system specialists through video conferencing, permitting paramedics to lay out associations. This empowers the opportune organization of basic medicines, including tissue plasminogen activator (tPA) or thrombectomy.

Moreover, ambulances outfitted with telemedicine abilities can add to preventive consideration, schooling, and populace wellbeing drives by leading remote observing, training, and follow-up administrations with patients in their networks or homes. By taking on a proactive position towards medical services conveyance, medical care variations can be moderated, patient commitment can be improved, and avoidable hospitalizations can be forestalled. These results bring about better wellbeing results for patients and cost investment funds for medical services frameworks.

Regional Insights

Over the projection period, Asia Pacific is anticipated to continue to have a dominant position. The growing incidence of chronic illnesses including diabetes, heart disease, and cancer is the main factor fueling the market boom for ambulance services in the Asia Pacific region. The prevalence of chronic illnesses is attributed to lifestyle factors such as obesity, sedentary behaviors, and tobacco use, which call for immediate medical care and emergency action. For example, estimates from the International Diabetes Federation (IDF) suggest that by 2030 and 2045, the number of diabetes cases in Southeast Asian nations will have significantly increased. Given that cardiovascular diseases (CVD) are the primary cause of death in the area, effective ambulance services are absolutely necessary. The data provided by the American College of Cardiology Foundation underscores the noteworthy influence of cardiovascular disease (CVD) on death rates in Asia. This underscores the critical function of ambulance services in delivering prompt and state-of-the-art medical care to patients undergoing heart-related catastrophes.

In addition, the market for ambulance services is expanding due to rising healthcare costs in the Asia Pacific area. Significant investments in healthcare infrastructure are being made in nations like China, which is improving the quality and accessibility of medical services. The increase in healthcare spending not only improves emergency response times but also expands the healthcare system, increasing the need for ambulance services with highly trained staff and cutting-edge equipment.

Major Players

Major Players in the Ambulance market includes Bergadana, Miesen GmbH & Co. KG, Braun Industries, Inc., BOLLANTI, EMS Mobil Sistemler A.S., RMA Special Vehicles, NAFFCO, Ambulancemed, American Specialty Vehicles, and Deltamed.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

• 3.1 OVERVIEW
• 3.2 DATA FLOW
  • 3.2.1 DATA MINING PROCESS
• 3.3 PURCHASED DATABASE:
• 3.4 SECONDARY SOURCES:
  • 3.4.1 SECONDARY RESEARCH DATA FLOW:
• 3.5 PRIMARY RESEARCH:
  • 3.5.1 PRIMARY RESEARCH DATA FLOW:
  • 3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
  • 3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE
• 3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
  • 3.6.1 CONSUMPTION & NET TRADE APPROACH
  • 3.6.2 REVENUE ANALYSIS APPROACH
• 3.7 DATA FORECASTING
  • 3.7.1 DATA FORECASTING TECHNIQUE
• 3.8 DATA MODELING
  • 3.8.1 MICROECONOMIC FACTOR ANALYSIS:
  • 3.8.2 DATA MODELING:
• 3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 THE PREVALENCE OF CHRONIC DISEASES LIKE HEART DISEASE, CANCER, AND DIABETES IS INCREASING GLOBALLY
  • 4.2.2 THE RISING GERIATRIC POPULATION WORLDWIDE FULLING THE DEMAND FOR HEALTHCARE FACILITIES, INCLUDING AMBULANCES
  • 4.2.3 GOVERNMENTS AND ORGANIZATIONS ARE INCREASINGLY INVESTING IN DISASTER PREPAREDNESS MEASURES
• 4.3 RESTRAINTS
  • 4.3.1 THE HIGH COST OF PURCHASING AND MAINTAINING AMBULANCES CAN BE A SIGNIFICANT BARRIER FOR SOME ORGANIZATIONS
  • 4.3.2 STRINGENT REGULATIONS REGARDING AMBULANCE DESIGN, EQUIPMENT, AND PERSONNEL
• 4.4 OPPORTUNITY
  • 4.4.1 INTEGRATION OF ADVANCED MEDICAL TECHNOLOGIES
  • 4.4.2 TECHNOLOGICAL ADVANCEMENTS IN AMBULANCES
  • 4.4.3 GROWING DEMAND FOR TRANSPORTING PATIENTS FOR APPOINTMENTS, TREATMENTS, AND DISCHARGES
• 4.5 CHALLENGES
  • 4.5.1 LIMITED HEALTHCARE INFRASTRUCTURE
  • 4.5.2 SHORTAGE OF SKILLED PERSONNEL
• 4.6 COVID-19 IMPACT ANALYSIS
  • 4.6.1 IMPACT ON OVERALL AUTOMOTIVE INDUSTRY
    • 4.6.1.1 ECONOMIC IMPACT
  • 4.6.2 IMPACT ON AMBULANCE MARKET
  • 4.6.3 IMPACT ON THE SUPPLY CHAIN OF AMBULANCE
    • 4.6.3.1 PRICE VARIATION OF KEY RAW MATERIALS
    • 4.6.3.2 PRODUCTION SHUTDOWN
    • 4.6.3.3 CASH FLOW CONSTRAINTS
    • 4.6.3.4 IMPACT ON IMPORT/EXPORT
  • 4.6.4 IMPACT ON MARKET DEMAND FOR AMBULANCE
    • 4.6.4.1 IMPACT DUE TO RESTRICTIONS/LOCKDOWN
    • 4.6.4.2 CONSUMER SENTIMENTS
• 4.7 MARKET TRENDS
  • 4.7.1 INCREASING ADOPTION OF TELEMEDICINE TECHNOLOGIES AND INTEGRATED HEALTHCARE SOLUTIONS
  • 4.7.2 INCREASING FOCUS ON SUSTAINABILITY AND THE ADOPTION OF ENVIRONMENTALLY-FRIENDLY AMBULANCE VEHICLES

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 RAW MATERIALS
  • 5.1.2 MANUFACTURING / PRODUCTION/ PROCESSING
  • 5.1.3 DISTRIBUTION AND SALES
  • 5.1.4 SERVICE AND SUPPORT
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 BARGAINING POWER OF SUPPLIERS
  • 5.2.2 BARGAINING POWER OF BUYERS
  • 5.2.3 THREAT OF NEW ENTRANTS
  • 5.2.4 THREAT OF SUBSTITUTES
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 MARKET SWOT ANALYSIS
• 5.4 MARKET PESTEL ANALYSIS
  • 5.4.1 POLITICAL
  • 5.4.2 ECONOMICAL
  • 5.4.3 SOCIAL
  • 5.4.4 TECHNOLOGICAL
  • 5.4.5 ENVIRONMENT
  • 5.4.6 LEGAL
• 5.5 PATENT TREND ANALYSIS
• 5.6 REGULATORY OUTLOOK
• 5.7 CURRENT MARKET OUTLOOK & PROSPECTS
• 5.8 FUTURE INNOVATIONS
• 5.9 PRICING TRENDS ANALYSIS ($/UNIT)

6 GLOBAL AMBULANCE MARKET, BY STANDARD

• 6.1 OVERVIEW

7 GLOBAL AMBULANCE MARKET, BY VARIANT

• 7.1 OVERVIEW

8 GLOBAL AMBULANCE MARKET, BY SIZE

• 8.1 OVERVIEW

9 GLOBAL AMBULANCE MARKET, BY PROPULSION

• 9.1 OVERVIEW

10 GLOBAL AMBULANCE MARKET, BY APPLICATION

• 10.1 OVERVIEW

11 GLOBAL AMBULANCE MARKET, BY TRANSMISSION TYPE

• 11.1 OVERVIEW

12 GLOBAL AMBULANCE MARKET, BY REGION

• 12.1 GLOBAL
• 12.2 NORTH AMERICA
• 12.3 EUROPE
• 12.4 ASIA PACIFIC
• 12.5 MIDDLE EAST & AFRICA
• 12.6 SOUTH & CENTRAL AMERICA

13 COMPETITIVE LANDSCAPE

• 13.1 INTRODUCTION
• 13.2 COMPETITION DASHBOARD
  • 13.2.1 PRODUCT PORTFOLIO
  • 13.2.2 REGIONAL PRESENCE
  • 13.2.3 STRATEGIC ALLIANCES
  • 13.2.4 INDUSTRY EXPERIENCES
• 13.3 MARKET SHARE ANALYSIS, 127
• 13.4 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 13.4.1 PRODUCT LAUNCH & DONATION
  • 13.4.2 PARTNERSHIP & AGREEMENT
  • 13.4.3 EXPANSION

14 COMPANY PROFILES

• 14.1 BOLLANTI
  • 14.1.1 COMPANY OVERVIEW
  • 14.1.2 PRODUCTS OFFERED
  • 14.1.3 SWOT ANALYSIS
  • 14.1.4 KEY STRATEGY
• 14.2 EMS MOBIL SISTEMLER A.S.
  • 14.2.1 COMPANY OVERVIEW
  • 14.2.2 PRODUCTS OFFERED
  • 14.2.3 SWOT ANALYSIS
  • 14.2.4 KEY STRATEGY
• 14.3 RMA GROUP
  • 14.3.1 COMPANY OVERVIEW
  • 14.3.2 PRODUCTS OFFERED
  • 14.3.3 KEY DEVELOPMENTS
  • 14.3.4 SWOT ANALYSIS
  • 14.3.5 KEY STRATEGY
• 14.4 NAFFCO GROUP
  • 14.4.1 COMPANY OVERVIEW
  • 14.4.2 PRODUCTS OFFERED
  • 14.4.3 KEY DEVELOPMENTS
  • 14.4.4 SWOT ANALYSIS
  • 14.4.5 KEY STRATEGY
• 14.5 BRAUN INDUSTRIES, INC
  • 14.5.1 COMPANY OVERVIEW
  • 14.5.2 PRODUCTS OFFERED
  • 14.5.3 KEY DEVELOPMENTS
  • 14.5.4 SWOT ANALYSIS
  • 14.5.5 KEY STRATEGY
• 14.6 AMBULANCEMED
  • 14.6.1 COMPANY OVERVIEW
  • 14.6.2 PRODUCTS OFFERED
  • 14.6.3 KEY DEVELOPMENTS
  • 14.6.4 SWOT ANALYSIS
  • 14.6.5 KEY STRATEGY
• 14.7 AMERICAN SPECIALITY VEHICLES
  • 14.7.1 COMPANY OVERVIEW
  • 14.7.2 PRODUCTS OFFERED
  • 14.7.3 SWOT ANALYSIS
  • 14.7.4 KEY STRATEGY
• 14.8 BERGADANA
  • 14.8.1 COMPANY OVERVIEW
  • 14.8.2 PRODUCTS OFFERED
  • 14.8.3 KEY DEVELOPMENTS
  • 14.8.4 SWOT ANALYSIS
  • 14.8.5 KEY STRATEGY
• 14.9 C. MIESEN GMBH & CO. KG
  • 14.9.1 COMPANY OVERVIEW
  • 14.9.2 PRODUCTS OFFERED
  • 14.9.3 KEY DEVELOPMENTS
  • 14.9.4 SWOT ANALYSIS
  • 14.9.5 KEY STRATEGY
• 14.10 DELTAMED
  • 14.10.1 COMPANY OVERVIEW
  • 14.10.2 PRODUCTS OFFERED
  • 14.10.3 KEY DEVELOPMENTS
  • 14.10.4 SWOT ANALYSIS
  • 14.10.5 KEY STRATEGY

15 APPENDIX

• 15.1 REFERENCES
• 15.2 RELATED REPORTS